You searched for "proptosis"
Introducing the Surgitrac Information Hub: A New Resource for Ophthalmic Professionals
Finding reliable, practical information in ophthalmology should not feel difficult. That is why Surgitrac has launched its brand-new Information Hub, a dedicated online resource designed to support surgeons, theatre teams, nurses and procurement professionals with trusted educational content and essential...Rayner champions earlier conversations about cataract lens options
Cataract surgery is the most frequently performed operation in the UK, with an estimate of 960,000 procedures in 2026i. As demand continues to rise, so does the importance of helping patients understand the intraocular lens choices available to them. For...Visit Surgitrac Instruments at ESCRS 2026 | Hall B, Booth B.339
The countdown is on for the 44th Congress of the European Society of Cataract and Refractive Surgeons (ESCRS), taking place from 11–15 September 2026 at ExCeL London. As one of Europe's leading ophthalmic events, ESCRS brings together surgeons, theatre teams,...Heidelberg Engineering announces expansion of market access for digital surgical visualization platform
Heidelberg Engineering today announced the upcoming commercialization of Heidelberg OPERA®*, its fully digital surgical visualisation platform, which will be introduced through the company’s global sales force and distribution network. Heidelberg OPERA® is centred around a fully digital surgical microscope which...
Practical Medical Retina: Navigating the Net
I wasn’t sure if reviewing a book whilst on maternity leave with a demanding (but cute) baby was a good idea. However, this textbook was so easy to read I could understand it even when I was mildly sleep deprived....
Two-year GATHER2 data: anatomical gains, functional questions for avacincaptad pegol in geographic atrophy
Geographic atrophy (GA) secondary to age-related macular degeneration (AMD) remains a leading cause of irreversible central vision loss, and complement dysregulation has long been implicated in its pathogenesis. In 2023, the US FDA approved the first two GA therapies, both...
